CCR2 and arthritic joint disease: Consistent with our previous observations in mice and humans, we observed an increase in CD2+MHC-II+CCR2+ myeloid precursors and a significant decrease in CD200+ fibroblasts in the synovial tissue during the onset of arthritis in humans (Fig. 5d).